This page lists all known medications that could potentially lead to 'Involuntary Movements' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Adrian is the first paediatric patient with GNAO1 in Asia to undergo Deep Brain Stimulation surgery for this condition. SINGAPORE – Fewer than 500 people worldwide are known to have a rare genetic ...

Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure. | Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to ...

People with autism spectrum disorder (ASD) and intellectual disability (ID) often experience involuntary movements, which disrupt their ability to perform many tasks. A new device could help reduce ...

The case description for a Case Records of the Massachusetts General Hospital appears below. What is the diagnosis? Cast your vote. The correct diagnosis, along with the full description of the case ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants who ...

Dyskinesia is a state in which someone experiences involuntary movements. Chorea is a type of dyskinesia. Other types of dyskinesia include tics, myoclonus, dystonia, and akathisia. There are ...

Neurocrine Biosciences said on Monday its drug failed to meet the main goal in a late-stage clinical trial in patients with a type of disorder that disrupts the brain's ability to control muscles.

PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the ...

When picturing signs of dementia to look for, the first ones that come to mind may be memory loss, struggling to think of the right word and having difficulty problem-solving. You may have also heard ...